MedPath

A clinical trial to study the effect of the drug megarajanga kirutham in patients having menorrhagia (pitha perumbadu)

Phase 2
Conditions
Health Condition 1: N922- Excessive menstruation at puberty
Registration Number
CTRI/2019/08/020767
Lead Sponsor
Gocernment siddha medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Excessive menstruation prologed menstruation puberty menorrhagia premenoppausal menorrhagis

Exclusion Criteria

Fibroid polyp adenomyosis bleeding disorders ovarian feminizing tumour uterine fibroids chocolate cyst hypothyroidism abortion and pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
outcome is mainly assessed by reduction in clinical symptoms and by comparing the parameters before and after treatmentTimepoint: 1 year
Secondary Outcome Measures
NameTimeMethod
Reduced amount of blood flow ia assessed by number of sanitary pads used before and after treatmentTimepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath